Effect of lasiocarpine on aflatoxin B 1  carcinogenicity in rat liver.
D000284:Administration, Oral; D000348:Aflatoxins / Q000008:administration & dosage; D000470:Alkaloids; D000818:Animals; D002273:Carcinogens; D056486:Chemical and Drug Induced Liver Injury; D004032:Diet; D004357:Drug Synergism; D006571:Heterocyclic Compounds; D007274:Injections, Intraperitoneal; D008103:Liver Cirrhosis / Q000139:chemically induced / Q000473:pathology; D008107:Liver Diseases / Q000473:pathology; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000473:pathology; D008297:Male; D011763:Pyrrolizidine Alkaloids / Q000008:administration & dosage; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
D000348:Aflatoxins; D000470:Alkaloids; D002273:Carcinogens; D006571:Heterocyclic Compounds; D011763:Pyrrolizidine Alkaloids